Omnicell, Inc. (OMCL)
Price:
40.15 USD
( + 0.59 USD)
Your position:
0 USD
ACTION PANEL
ABOUT
Check the
KEY TAKEAWAYS
ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)
(REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION
SIMILAR COMPANIES STI SCORE
Similar STI Score
GE HealthCare Technologies Inc.
VALUE SCORE:
6
2nd position
CareCloud, Inc.
VALUE SCORE:
9
The best
Progyny, Inc.
VALUE SCORE:
9
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS PER SHARE
TECHNICAL
DIVIDEND
SIMILAR COMPANIES
DESCRIPTION
Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; Omnicell Interface Software that offers interface and integration between its medication-use products or supply products, and a healthcare facility's in-house information management systems; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions, including automated storage and retrieval systems, such as XR2 Automated Central Pharmacy System; IV compounding robots and workflow management systems; inventory management software; and controlled substance management systems. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based nexus of solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Mountain View, California.
NEWS
Hillsdale Investment Management Inc. Purchases 41,500 Shares of Omnicell, Inc. $OMCL
defenseworld.net
2026-02-23 05:38:50Hillsdale Investment Management Inc. boosted its position in Omnicell, Inc. (NASDAQ: OMCL) by 40.3% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 144,427 shares of the company's stock after acquiring an additional 41,500 shares during the period. Hillsdale Investment
Omnicell (NASDAQ:OMCL) Shares Gap Down on Disappointing Earnings
defenseworld.net
2026-02-06 01:56:51Shares of Omnicell, Inc. (NASDAQ: OMCL - Get Free Report) gapped down before the market opened on Thursday following a dissappointing earnings announcement. The stock had previously closed at $46.69, but opened at $39.69. Omnicell shares last traded at $38.38, with a volume of 552,117 shares changing hands. The company reported $0.40 earnings per share for
Omnicell, Inc. (OMCL) Q4 2025 Earnings Call Transcript
seekingalpha.com
2026-02-05 19:24:20Omnicell, Inc. (OMCL) Q4 2025 Earnings Call Transcript
Omnicell (OMCL) Q4 Earnings Lag Estimates
zacks.com
2026-02-05 08:46:09Omnicell (OMCL) came out with quarterly earnings of $0.4 per share, missing the Zacks Consensus Estimate of $0.47 per share. This compares to earnings of $0.6 per share a year ago.
Omnicell Announces Fiscal Year and Fourth Quarter 2025 Financial Results
businesswire.com
2026-02-05 06:30:00FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell Announces Fiscal Year and Fourth Quarter 2025 Financial Results.
Omnicell, Inc. (NASDAQ:OMCL) Receives Average Recommendation of “Hold” from Analysts
defenseworld.net
2026-02-02 02:00:53Omnicell, Inc. (NASDAQ: OMCL - Get Free Report) has received an average rating of "Hold" from the eight ratings firms that are covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and four have issued a buy rating on the company.
OMCL or HIMS: Which Is the Better Value Stock Right Now?
zacks.com
2026-01-30 12:40:36Investors interested in stocks from the Medical Info Systems sector have probably already heard of Omnicell (OMCL) and Hims & Hers Health, Inc. (HIMS). But which of these two stocks presents investors with the better value opportunity right now?
Earnings Preview: Omnicell (OMCL) Q4 Earnings Expected to Decline
zacks.com
2026-01-29 11:06:19Omnicell (OMCL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
3 Medical Info Systems Stocks to Gain From Digitization Despite Industry Woes
zacks.com
2026-01-21 10:56:10Medical Info Systems rides AI and telehealth tailwinds, lifting DOCS, TXG and OMCL, but cyber risks and industry underperformance keep optimism in check.
Careview Communications (OTCMKTS:CRVW) & Omnicell (NASDAQ:OMCL) Critical Analysis
defenseworld.net
2026-01-19 02:10:44Omnicell (NASDAQ: OMCL - Get Free Report) and Careview Communications (OTCMKTS:CRVW - Get Free Report) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, institutional ownership, earnings, dividends, analyst recommendations, valuation and profitability. Risk and Volatility Omnicell has a beta of 0.77,
All You Need to Know About Omnicell (OMCL) Rating Upgrade to Buy
zacks.com
2026-01-13 13:01:03Omnicell (OMCL) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
OMCL vs. HIMS: Which Stock Is the Better Value Option?
zacks.com
2026-01-13 12:41:21Investors interested in stocks from the Medical Info Systems sector have probably already heard of Omnicell (OMCL) and Hims & Hers Health, Inc. (HIMS). But which of these two stocks presents investors with the better value opportunity right now?
Omnicell to Release Fourth Quarter and Full Year 2025 Financial Results on February 5, 2026
businesswire.com
2026-01-13 08:01:00FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell to Release Fourth Quarter and Full Year 2025 Financial Results on February 5, 2026.
Omnicell Executive Trims Holdings in $244,000 Sale as Stock Trades Near 2025 Highs
fool.com
2026-01-05 15:33:546,106 shares were sold for a transaction value of $243,629 on Dec. 3, 2025. The sale represented 5.85% of direct holdings, reducing direct ownership to 98,282 shares (0.2122% of shares outstanding).
Best Momentum Stocks to Buy for Dec. 16
zacks.com
2025-12-16 11:01:13PAAS, OMCL and MDB made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on Dec. 16, 2025.
New Strong Buy Stocks for Dec. 16: MDB, OMCL, and More
zacks.com
2025-12-16 06:46:04COF, QCRH, TNET, MDB and OMCL have been added to the Zacks Rank #1 (Strong Buy) List on Dec. 16, 2025.
No data to display
Hillsdale Investment Management Inc. Purchases 41,500 Shares of Omnicell, Inc. $OMCL
defenseworld.net
2026-02-23 05:38:50Hillsdale Investment Management Inc. boosted its position in Omnicell, Inc. (NASDAQ: OMCL) by 40.3% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 144,427 shares of the company's stock after acquiring an additional 41,500 shares during the period. Hillsdale Investment
Omnicell (NASDAQ:OMCL) Shares Gap Down on Disappointing Earnings
defenseworld.net
2026-02-06 01:56:51Shares of Omnicell, Inc. (NASDAQ: OMCL - Get Free Report) gapped down before the market opened on Thursday following a dissappointing earnings announcement. The stock had previously closed at $46.69, but opened at $39.69. Omnicell shares last traded at $38.38, with a volume of 552,117 shares changing hands. The company reported $0.40 earnings per share for
Omnicell, Inc. (OMCL) Q4 2025 Earnings Call Transcript
seekingalpha.com
2026-02-05 19:24:20Omnicell, Inc. (OMCL) Q4 2025 Earnings Call Transcript
Omnicell (OMCL) Q4 Earnings Lag Estimates
zacks.com
2026-02-05 08:46:09Omnicell (OMCL) came out with quarterly earnings of $0.4 per share, missing the Zacks Consensus Estimate of $0.47 per share. This compares to earnings of $0.6 per share a year ago.
Omnicell Announces Fiscal Year and Fourth Quarter 2025 Financial Results
businesswire.com
2026-02-05 06:30:00FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell Announces Fiscal Year and Fourth Quarter 2025 Financial Results.
Omnicell, Inc. (NASDAQ:OMCL) Receives Average Recommendation of “Hold” from Analysts
defenseworld.net
2026-02-02 02:00:53Omnicell, Inc. (NASDAQ: OMCL - Get Free Report) has received an average rating of "Hold" from the eight ratings firms that are covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and four have issued a buy rating on the company.
OMCL or HIMS: Which Is the Better Value Stock Right Now?
zacks.com
2026-01-30 12:40:36Investors interested in stocks from the Medical Info Systems sector have probably already heard of Omnicell (OMCL) and Hims & Hers Health, Inc. (HIMS). But which of these two stocks presents investors with the better value opportunity right now?
Earnings Preview: Omnicell (OMCL) Q4 Earnings Expected to Decline
zacks.com
2026-01-29 11:06:19Omnicell (OMCL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
3 Medical Info Systems Stocks to Gain From Digitization Despite Industry Woes
zacks.com
2026-01-21 10:56:10Medical Info Systems rides AI and telehealth tailwinds, lifting DOCS, TXG and OMCL, but cyber risks and industry underperformance keep optimism in check.
Careview Communications (OTCMKTS:CRVW) & Omnicell (NASDAQ:OMCL) Critical Analysis
defenseworld.net
2026-01-19 02:10:44Omnicell (NASDAQ: OMCL - Get Free Report) and Careview Communications (OTCMKTS:CRVW - Get Free Report) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, institutional ownership, earnings, dividends, analyst recommendations, valuation and profitability. Risk and Volatility Omnicell has a beta of 0.77,
All You Need to Know About Omnicell (OMCL) Rating Upgrade to Buy
zacks.com
2026-01-13 13:01:03Omnicell (OMCL) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
OMCL vs. HIMS: Which Stock Is the Better Value Option?
zacks.com
2026-01-13 12:41:21Investors interested in stocks from the Medical Info Systems sector have probably already heard of Omnicell (OMCL) and Hims & Hers Health, Inc. (HIMS). But which of these two stocks presents investors with the better value opportunity right now?
Omnicell to Release Fourth Quarter and Full Year 2025 Financial Results on February 5, 2026
businesswire.com
2026-01-13 08:01:00FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell to Release Fourth Quarter and Full Year 2025 Financial Results on February 5, 2026.
Omnicell Executive Trims Holdings in $244,000 Sale as Stock Trades Near 2025 Highs
fool.com
2026-01-05 15:33:546,106 shares were sold for a transaction value of $243,629 on Dec. 3, 2025. The sale represented 5.85% of direct holdings, reducing direct ownership to 98,282 shares (0.2122% of shares outstanding).
Best Momentum Stocks to Buy for Dec. 16
zacks.com
2025-12-16 11:01:13PAAS, OMCL and MDB made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on Dec. 16, 2025.
New Strong Buy Stocks for Dec. 16: MDB, OMCL, and More
zacks.com
2025-12-16 06:46:04COF, QCRH, TNET, MDB and OMCL have been added to the Zacks Rank #1 (Strong Buy) List on Dec. 16, 2025.